Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 7, 2007; 13(33): 4458-4466
Published online Sep 7, 2007. doi: 10.3748/wjg.v13.i33.4458
Published online Sep 7, 2007. doi: 10.3748/wjg.v13.i33.4458
Figure 2 MS-275-induced LDH release into the supernatant of EGI-1 and TFK-1 cells.
mean ± SEM, n > 3 independent experiments; No significant increase in LDH release was observed.
- Citation: Baradari V, Höpfner M, Huether A, Schuppan D, Scherübl H. Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells. World J Gastroenterol 2007; 13(33): 4458-4466
- URL: https://www.wjgnet.com/1007-9327/full/v13/i33/4458.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i33.4458